This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Epocrates EHR For Small Group And Solo Physician Practices Enters Beta

Stocks in this article: EPOC

SAN MATEO, Calif., March 30, 2011 (GLOBE NEWSWIRE) -- Epocrates, Inc. (Nasdaq:EPOC), today announced its mobile and web-based electronic health record (EHR) solution has entered beta and is now being tested by solo and small group physician offices across the country. The company also announced an agreement with Nuance Communications, Inc. (Nasdaq:NUAN) to leverage the Nuance Healthcare Development Platform (NHDP) to integrate Nuance's cloud-based, medical speech recognition technology as a component of its Epocrates EHRâ„¢ solution.

"The beta installations and Nuance agreement are two significant milestones on our EHR development roadmap," said Rose Crane, president and chief executive officer of Epocrates. "Solo and small group physician practices have specific EHR needs that are going unmet. Collaborating with them through this beta period allows us to refine the product so it provides the best user experience."

The family practitioner offices participating in the closed beta have the opportunity to experience the flexibility of Epocrates' EHR system. Features in the beta include built-in workflow and clinical templates for specific procedures. A feature that is planned for a future EHR version is SpeechAnywhere, integrated Nuance medical speech recognition technology, which will empower medical professionals to create medical reports - anytime, anywhere (in exam rooms, offices, labs or in the field) and on any device (desktop, iPhone®, iPad®, etc.) via voice input. Physicians will benefit from the flexibility in creating clinical documentation and will gain clinical efficiency from the immediate availability of clinical notes, leading to faster, higher quality patient care.

"I have looked at many different EHR systems, but didn't have a lot of time to spend learning new software and implementing it into my practice. I've always valued Epocrates and the fact that its products don't require me to change the way I work. The new EHR and the company's first class support staff make for an easy, smooth, non-intimidating transition from paper-based to electronic records," said Dr. Bradley Stoltz, DO, family practitioner, Trevose, Pa.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs